Search Tag: fondaparinux
2015 17 Feb
According to a study published in JAMA, patients who receive fondaparinux after a certain type of heart attack had a lower risk of major bleeding events and death in the hospital and after six months as compared to patients who received low molecular weight heparin (LMWH). Both groups of patients had similar rates of subsequent heart attack or stroke....Read more
2014 07 Nov
A research team from the University of British Columbia has set out on making the use of heparin much safer by developing a universal antidote. Heparin, a lifesaving blood thinner that is used in major surgeries and treatment of heart disease, often requires an antidote to reverse its action and prevent serious bleeding issues in major surgical...Read more